CSACI Position Statement: Newer Generation H1-Antihistamines Are Safer Than First-Generation H1-Antihistamines and Should Be the First-Line Antihistamines for the Treatment of Allergic Rhinitis and Urticaria
Allergy, Asthma and Clinical Immunology- United Kingdom
doi 10.1186/s13223-019-0375-9
Full Text
Abstract
Available in
Date
October 1, 2019
Authors
Publisher
Springer Science and Business Media LLC